Molecular and Pharmacodynamic Interactions Between Caffeine and Dopaminergic System

Overview

Journal J Med Life

Specialty General Medicine

Date 2016 Apr 9

PMID 27057246

Citations 1

Authors

M Voiculescu

I Ghita

A Segarceanu

I Fulga

O Coman

Affiliations

Soon will be listed here.

Abstract

Many drugs targeting dopaminergic system were developed for treating schizophrenia (antagonists of D2 dopaminergic receptors, e.g. antipsychotics) or Parkinson' disease (agonists of dopaminergic receptors, e.g. L-DOPA). Because many of the patients treated with these drugs consume caffeine based beverages, pharmacodynamics and pharmacokinetics interactions between caffeine and dopaminergic system or drugs influencing this system are possible. The present review is assessing the current available scientific data on pharmacodynamics interactions between the dopaminergic and adenosinergic system but also on caffeine and dopaminergic system interactions. Caffeine can significantly improve Parkinson's disease symptoms but also the extrapyramidal syndrome induced by antipsychotics via dopaminergic pathways. No study so far has directly evaluated the influence of caffeine in schizophrenia, but there is growing evidence that adenosine dysfunction may contribute to the neurobiological and clinical features of schizophrenia. Caffeine has also effects on the reward system but it seems that this effect does not involve dopaminergic system. Caffeine has some endocrine effects via dopaminergic system such as decreasing the milk production in lactating women or other potential reproductive and nutritional consequences.

Citing Articles

The Influence of a Xanthine-Catechin Chemical Matrix on in vitro Macrophage-Activation Triggered by Antipsychotic Ziprasidone.

Duarte T, Barbisan F, da Cunha B, Azzolin V, Turra B, Duarte M Inflammation. 2018; 42(3):915-925.

PMID: 30547260 DOI: 10.1007/s10753-018-0946-9.

References

Schultz W, Dayan P, Montague P . A neural substrate of prediction and reward. Science. 1997; 275(5306):1593-9. DOI: 10.1126/science.275.5306.1593. View

Fuxe K, Agnati L, Jacobsen K, Hillion J, Canals M, Torvinen M . Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology. 2003; 61(11 Suppl 6):S19-23. DOI: 10.1212/01.wnl.0000095206.44418.5c. View

Acuna-Lizama M, Bata-Garcia J, Alvarez-Cervera F, Gongora-Alfaro J . Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats. Neuropharmacology. 2013; 70:51-62. DOI: 10.1016/j.neuropharm.2013.01.002. View

Zahniser N, Simosky J, Mayfield R, Negri C, Hanania T, Larson G . Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors. J Neurosci. 2000; 20(16):5949-57. PMC: 6772613. View

Wardle M, Treadway M, de Wit H . Caffeine increases psychomotor performance on the effort expenditure for rewards task. Pharmacol Biochem Behav. 2012; 102(4):526-31. PMC: 3578395. DOI: 10.1016/j.pbb.2012.06.016. View

Akhondzadeh S, Shasavand E, Jamilian H, Shabestari O, Kamalipour A . Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J Clin Pharm Ther. 2000; 25(2):131-7. DOI: 10.1046/j.1365-2710.2000.00273.x. View

Ridley R, Baker H, Frith C, Dowdy J, Crow T . Stereotyped responding on a two-choice guessing task by marmosets and humans treated with amphetamine. Psychopharmacology (Berl). 1988; 95(4):560-4. DOI: 10.1007/BF00172977. View

Sturgess J, Ting-A-Kee R, Podbielski D, Sellings L, Chen J, van der Kooy D . Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects. Eur J Neurosci. 2010; 32(1):143-54. PMC: 2994015. DOI: 10.1111/j.1460-9568.2010.07247.x. View

Salamone J, Carlson B, Rios C, Lentini E, Correa M, Wisniecki A . Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243. Behav Brain Res. 2004; 156(2):173-9. DOI: 10.1016/j.bbr.2004.05.019. View

10.

Kaasinen V, Aalto S, Nagren K, Rinne J . Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci. 2004; 19(8):2352-6. DOI: 10.1111/j.1460-9568.2004.03310.x. View

11.

Beninger R . The role of dopamine in locomotor activity and learning. Brain Res. 1983; 287(2):173-96. DOI: 10.1016/0165-0173(83)90038-3. View

12.

Garrett B, Holtzman S . D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol Biochem Behav. 1994; 47(1):89-94. DOI: 10.1016/0091-3057(94)90115-5. View

13.

Botzung A, Denkova E, Manning L . Experiencing past and future personal events: functional neuroimaging evidence on the neural bases of mental time travel. Brain Cogn. 2007; 66(2):202-12. DOI: 10.1016/j.bandc.2007.07.011. View

14.

Lara D, DallIgna O, Ghisolfi E, Brunstein M . Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(4):617-29. DOI: 10.1016/j.pnpbp.2006.02.002. View

15.

Doherty M, Smith P . Effects of caffeine ingestion on rating of perceived exertion during and after exercise: a meta-analysis. Scand J Med Sci Sports. 2005; 15(2):69-78. DOI: 10.1111/j.1600-0838.2005.00445.x. View

16.

Kebabian J, Calne D . Multiple receptors for dopamine. Nature. 1979; 277(5692):93-6. DOI: 10.1038/277093a0. View

17.

Trivedi J . Cognitive deficits in psychiatric disorders: Current status. Indian J Psychiatry. 2010; 48(1):10-20. PMC: 2913637. DOI: 10.4103/0019-5545.31613. View

18.

Salamone J . Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders. IDrugs. 2010; 13(10):723-31. View

19.

Okuda J, Fujii T, Ohtake H, Tsukiura T, Tanji K, Suzuki K . Thinking of the future and past: the roles of the frontal pole and the medial temporal lobes. Neuroimage. 2003; 19(4):1369-80. DOI: 10.1016/s1053-8119(03)00179-4. View

20.

Hall S, Schallert T . Striatal dopamine and the interface between orienting and ingestive functions. Physiol Behav. 1988; 44(4-5):469-71. DOI: 10.1016/0031-9384(88)90307-1. View